PFS
CCXI

Prospera Financial Services’s ChemoCentryx, Inc. CCXI Stock Holding History

Prospera Financial Services’s Portfolio CCXI Stock Details CCXI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,828
Closed -$46K – 2789
2022
Q1 		$46K Buy
+1,828
New +$51.4K ﹤0.01% 1416
2020
Q4 		– Sell
-527
Closed -$29K – 1677
2020
Q3 		$29K Buy
+527
New +$28.4K 0.01% 793

Other funds holding CCXI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Prospera Financial Services's CCXI Position: Q2 2022 in Review

Prospera Financial Services sold out of ChemoCentryx, Inc. (CCXI) in Q2 2022, closing a stake of 1,828 shares — an estimated $46K sold.

Prospera Financial Services first reported a position in CCXI in Q3 2020 and held it in 2 quarters. The position peaked at $46K in Q1 2022. 182 funds tracked by Wall St. Rank hold CCXI as of Q2 2022.

  • Prospera Financial Services reported no remaining ChemoCentryx, Inc. position as of Q2 2022 after selling out during the quarter.
  • Prospera Financial Services sold 1,828 ChemoCentryx, Inc. shares in Q2 2022, an estimated $46K.
  • Prospera Financial Services first reported a position in ChemoCentryx, Inc. in Q3 2020 and held it in 2 quarters.
  • Prospera Financial Services's ChemoCentryx, Inc. position peaked at $46K in Q1 2022.
  • 182 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q2 2022.

Based on Prospera Financial Services's 13F filing for Q2 2022, filed 8 Aug 2022.